Clinical trial
Intracolonic Vancomycin Therapy in Severe C. Diff Colitis: A Double Blinded Randomized Prospective Trial
NCT01346059 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intracolonic Vancomycin Therapy in Severe C. Diff Colitis: A Double Blinded Randomized Prospective Trial
- Lead sponsor
- Corewell Health East
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2011
- Completion date
- February 29, 2012
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.